The China CAR T cell therapy market encompasses a diverse range of therapeutic areas, cell sources, and indications that are driving innovation in cancer treatment. From the dominant oncology segment to the emerging autoimmune diseases applications, and from autologous therapies that use a patient's own cells to allogeneic therapies that leverage donor cells, the market offers a comprehensive...